Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?

Brittany N Dugger; Danielle Harvey; Thomas G Beach; Charles H Adler

doi:10.1093/brain/awac281

Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?

Brain. 2022 Aug 27;145(8):2629-2631. doi: 10.1093/brain/awac281.

Authors

Brittany N Dugger¹, Danielle Harvey², Thomas G Beach³, Charles H Adler⁴

Affiliations

¹ Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA 95817, USA.
² Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Davis, CA 95616, USA.
³ Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ 85351, USA.
⁴ Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA.

Abstract

This scientific commentary refers to ‘Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies’ by Vacchi et al. (https://doi.org/10.1093/brain/awac161).

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Comment

MeSH terms

Biomarkers
Biopsy
Humans
Neurodegenerative Diseases*
Synucleinopathies*
Tauopathies*
tau Proteins

Substances

Biomarkers
tau Proteins

Abstract

Publication types

MeSH terms

Substances

Grants and funding